Ballentine Partners’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,880
Closed -$248K 960
2024
Q4
$248K Hold
2,880
﹤0.01% 687
2024
Q3
$283K Hold
2,880
﹤0.01% 615
2024
Q2
$267K Hold
2,880
﹤0.01% 601
2024
Q1
$268K Hold
2,880
0.01% 578
2023
Q4
$250K Hold
2,880
0.01% 563
2023
Q3
$237K Sell
2,880
-225
-7% -$19.1K 0.01% 501
2023
Q2
$264K Buy
+3,105
New +$265K 0.01% 472
2017
Q4
Sell
-380
Closed -$21K 397
2017
Q3
$21K Hold
380
﹤0.01% 423
2017
Q2
$21K Buy
+380
New +$20.2K ﹤0.01% 417
2017
Q1
Sell
-380
Closed -$18K 273
2016
Q4
$18K Hold
380
﹤0.01% 190
2016
Q3
$19K Buy
+380
New +$19.5K ﹤0.01% 200

Other funds holding IXJ

Ballentine Partners's IXJ Position: Q1 2025 in Review

Ballentine Partners sold out of iShares Global Healthcare ETF (IXJ) in Q1 2025, closing a stake of 2,880 shares — an estimated $248K sold.

Ballentine Partners first reported a position in IXJ in Q3 2016 and held it in 11 quarters. The position peaked at $283K in Q3 2024. 266 funds tracked by Wall St. Rank hold IXJ as of Q1 2025.

  • Ballentine Partners reported no remaining iShares Global Healthcare ETF position as of Q1 2025 after selling out during the quarter.
  • Ballentine Partners sold 2,880 iShares Global Healthcare ETF shares in Q1 2025, an estimated $248K.
  • Ballentine Partners first reported a position in iShares Global Healthcare ETF in Q3 2016 and held it in 11 quarters.
  • Ballentine Partners's iShares Global Healthcare ETF position peaked at $283K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2025.

Based on Ballentine Partners's 13F filing for Q1 2025, filed 1 May 2025.